118 related articles for article (PubMed ID: 1827843)
1. Synthesis and in vitro evaluation of 2,3-dimethoxy-5-(fluoroalkyl)-substituted benzamides: high-affinity ligands for CNS dopamine D2 receptors.
Bishop JE; Mathis CA; Gerdes JM; Whitney JM; Eaton AM; Mailman RB
J Med Chem; 1991 May; 34(5):1612-24. PubMed ID: 1827843
[TBL] [Abstract][Full Text] [Related]
2. Potential antipsychotic agents. 9. Synthesis and stereoselective dopamine D-2 receptor blockade of a potent class of substituted (R)-N-[(1-benzyl-2-pyrrolidinyl)methyl]benzamides. Relations to other side chain congeners.
Högberg T; Ström P; de Paulis T; Stensland B; Csöregh I; Lundin K; Hall H; Ogren SO
J Med Chem; 1991 Mar; 34(3):948-55. PubMed ID: 1672158
[TBL] [Abstract][Full Text] [Related]
3. Potential antipsychotic agents. 7. Synthesis and antidopaminergic properties of the atypical highly potent (S)-5-bromo-2,3-dimethoxy-N-[(1-ethyl-2-pyrrolidinyl)methyl]benzamide and related compounds. A comparative study.
Högberg T; de Paulis T; Johansson L; Kumar Y; Hall H; Ogren SO
J Med Chem; 1990 Aug; 33(8):2305-9. PubMed ID: 1973734
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and binding properties of the fluorinated substituted benzamide [3H]NCQ 115, a new selective dopamine D2 receptor ligand.
Hall H; Högberg T; Halldin C; Bengtsson S; Wedel I
Eur J Pharmacol; 1991 Aug; 201(1):1-10. PubMed ID: 1686586
[TBL] [Abstract][Full Text] [Related]
5. Dopamine D-2 receptor imaging radiopharmaceuticals: synthesis, radiolabeling, and in vitro binding of (R)-(+)- and (S)-(-)-3-iodo-2-hydroxy-6-methoxy-N- [(1-ethyl-2-pyrrolidinyl)methyl]benzamide.
Kung HF; Kasliwal R; Pan SG; Kung MP; Mach RH; Guo YZ
J Med Chem; 1988 May; 31(5):1039-43. PubMed ID: 2966245
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of high affinity, aryl-substituted [18F]fluoropropylbenzamides for dopamine D-2 receptor studies.
Mathis CA; Bishop JE; Gerdes JM; Whitney JM; Brennan KM; Jagust WJ
Int J Rad Appl Instrum B; 1992 Jul; 19(5):571-88. PubMed ID: 1399687
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and structure-activity relationships of 4-amino-5-chloro-N-(1,4-dialkylhexahydro-1,4-diazepin-6-yl)-2-methoxybenzamide derivatives, novel and potent serotonin 5-HT3 and dopamine D2 receptors dual antagonist.
Hirokawa Y; Harada H; Yoshikawa T; Yoshida N; Kato S
Chem Pharm Bull (Tokyo); 2002 Jul; 50(7):941-59. PubMed ID: 12130853
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of N-substituted cis-N-methyl-2-(1-pyrrolidinyl)cyclohexylamines as high affinity sigma receptor ligands. Identification of a new class of highly potent and selective sigma receptor probes.
de Costa BR; Rice KC; Bowen WD; Thurkauf A; Rothman RB; Band L; Jacobson AE; Radesca L; Contreras PC; Gray NM
J Med Chem; 1990 Nov; 33(11):3100-10. PubMed ID: 2172538
[TBL] [Abstract][Full Text] [Related]
9. Substituted benzamides with conformationally restricted side chains. 2. Indolizidine derivatives as central dopamine receptor antagonists.
King FD; Hadley MS; McClelland CM
J Med Chem; 1988 Sep; 31(9):1708-12. PubMed ID: 2900897
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of omega-[18F]fluoroalkyl analogs of YM-09151-2 for the measurement of D2-dopamine receptors with PET.
Hatano K; Ido T; Ishiwata K; Hatazawa J; Itoh M; Kawashima K; Iwata R
Int J Rad Appl Instrum A; 1990; 41(6):551-5. PubMed ID: 2163373
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and in vitro affinity for dopamine D-2 receptor of N-fluorine-substituted analogs of eticlopride.
Fukumura T; Dohmoto H; Maeda M; Fukuzawa E; Kojima M
Chem Pharm Bull (Tokyo); 1990 Jun; 38(6):1740-2. PubMed ID: 2208388
[TBL] [Abstract][Full Text] [Related]
12. Effects of remoxipride and some related new substituted salicylamides on rat brain receptors.
Hall H; Sällemark M; Jerning E
Acta Pharmacol Toxicol (Copenh); 1986 Jan; 58(1):61-70. PubMed ID: 2869639
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of 5-[18F]fluoropropylepidepride as a potential PET radioligand for imaging dopamine D2 receptors.
Kessler RM; Votaw JR; de Paulis T; Bingham DR; Ansari MS; Mason NS; Holburn G; Schmidt DE; Votaw DB; Manning RG
Synapse; 1993 Nov; 15(3):169-76. PubMed ID: 8278895
[TBL] [Abstract][Full Text] [Related]
14. Preparation and biological evaluation of 18F-labeled benzamide analogs as potential dopamine D2 receptor ligands.
Kiesewetter DO; Kawai R; Chelliah M; Owens E; McLellan C; Blasberg RG
Int J Rad Appl Instrum B; 1990; 17(4):347-56. PubMed ID: 2143753
[TBL] [Abstract][Full Text] [Related]
15. The cloned dopamine D2 receptor reveals different densities for dopamine receptor antagonist ligands. Implications for human brain positron emission tomography.
Seeman P; Guan HC; Civelli O; Van Tol HH; Sunahara RK; Niznik HB
Eur J Pharmacol; 1992 Oct; 227(2):139-46. PubMed ID: 1358662
[TBL] [Abstract][Full Text] [Related]
16. Novel benzamides as selective and potent gastric prokinetic agents. 1. Synthesis and structure-activity relationships of N-[(2-morpholinyl)alkyl]benzamides.
Kato S; Morie T; Hino K; Kon T; Naruto S; Yoshida N; Karasawa T; Matsumoto J
J Med Chem; 1990 May; 33(5):1406-13. PubMed ID: 2139471
[TBL] [Abstract][Full Text] [Related]
17. Critical reevaluation of spiperone and benzamide binding to dopamine D2 receptors: evidence for identical binding sites.
Malmberg A; Jerning E; Mohell N
Eur J Pharmacol; 1996 May; 303(1-2):123-8. PubMed ID: 8804920
[TBL] [Abstract][Full Text] [Related]
18. Extrastriatal dopamine D2 receptors: distribution, pharmacological characterization and region-specific regulation by clozapine.
Janowsky A; Neve KA; Kinzie JM; Taylor B; de Paulis T; Belknap JK
J Pharmacol Exp Ther; 1992 Jun; 261(3):1282-90. PubMed ID: 1534844
[TBL] [Abstract][Full Text] [Related]
19. High affinity dopamine D2 receptor radioligands. 2. [125I]epidepride, a potent and specific radioligand for the characterization of striatal and extrastriatal dopamine D2 receptors.
Kessler RM; Ansari MS; Schmidt DE; de Paulis T; Clanton JA; Innis R; al-Tikriti M; Manning RG; Gillespie D
Life Sci; 1991; 49(8):617-28. PubMed ID: 1830917
[TBL] [Abstract][Full Text] [Related]
20. Fluorinated benzamide neuroleptics--III. Development of (S)-N-[(1-allyl-2-pyrrolidinyl)methyl]-5-(3-[18F]fluoropropyl)-2, 3-dimethoxybenzamide as an improved dopamine D-2 receptor tracer.
Mukherjee J; Yang ZY; Das MK; Brown T
Nucl Med Biol; 1995 Apr; 22(3):283-96. PubMed ID: 7627142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
